BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9650218)

  • 21. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
    Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
    Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow scintigraphy in the diagnosis of bone metastasis in prostate cancer.
    Fuse H; Nagakawa O; Seto H; Katayama T
    Int Urol Nephrol; 1994; 26(1):53-61. PubMed ID: 8026923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual bilateral Tc-99m DPD uptake on bone scan.
    Merk S; Hentschel M; Talazko J; Fischer R; Moser E
    Clin Nucl Med; 2003 Nov; 28(11):929-30. PubMed ID: 14578714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technical note: identifying the prostate cancer 'superscan' by quantitative skeletal scintigraphy.
    Hawkins T; Halewood MM
    Nucl Med Commun; 2008 Jul; 29(7):654-9. PubMed ID: 18528189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the bones and bone marrow in patients with metastatic carcinoma of the prostate: radiologic, cytologic and cytogenetic findings.
    Spiers AS; Deal DR; Kasimis BS; Miller BR
    J Med; 1982; 13(4):303-7. PubMed ID: 6957529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cancer of the prostate: value of bone scintigraphy. Point of view].
    Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
    Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography.
    Hayward SJ; McIvor J; Burdge AH; Jewkes RF; Williams G
    Br J Radiol; 1987 Jan; 60(709):79-81. PubMed ID: 3814999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow scintigraphy in Paget's disease of bone.
    Rudberg U; Ahlbäck SO; Udén R
    Acta Radiol; 1990 Mar; 31(2):141-4. PubMed ID: 2372457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
    Gulenchyn KY; Papoff W
    Clin Nucl Med; 1987 Jan; 12(1):45-6. PubMed ID: 3815996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The value of bone marrow scintigraphy in patients with recurrent breast cancer].
    Langer SW; Kamby C; Thomsen HS; Sørensen T; Hvid-Jacobsen K; Dombernowsky P; Nielsen SL
    Ugeskr Laeger; 1993 Mar; 155(11):778-82. PubMed ID: 8460428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiographic and scintigraphic skeletal imaging in patients with neuroblastoma: concise communication.
    Baker M; Siddiqui AR; Provisor A; Cohen MD
    J Nucl Med; 1983 Jun; 24(6):467-9. PubMed ID: 6854397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Skeletal scintigraphy for the observation of course and treatment of carcinoma of the prostate ].
    Pabst HW; Langhammer H; Schmid L; Sintermann R
    Rofo; 1981 Jul; 135(1):44-9. PubMed ID: 6288532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical manifestations and diagnostic approach to metastatic cancer of the mandible.
    Glaser C; Lang S; Pruckmayer M; Millesi W; Rasse M; Marosi C; Leitha T
    Int J Oral Maxillofac Surg; 1997 Oct; 26(5):365-8. PubMed ID: 9327288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy.
    Palestro CJ; Mehta HH; Patel M; Freeman SJ; Harrington WN; Tomas MB; Marwin SE
    J Nucl Med; 1998 Feb; 39(2):346-50. PubMed ID: 9476948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Massive skeletal metastasis: difficulties of bone scintigraphy, contribution of medullary scintigraphy].
    Blocklet D; Schoutens A
    Rev Med Brux; 1999 Apr; 20(2):A104-5. PubMed ID: 10335106
    [No Abstract]   [Full Text] [Related]  

  • 36. [Radionuclide diagnosis and therapy of skeletal metastases of prostatic cancer].
    Schümichen C
    Radiologe; 1984 Jan; 24(1):13-8. PubMed ID: 6200897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can bone marrow scintigraphy predict platelet toxicity after treatment with 186Re-HEDP?
    de Klerk JM; Zonnenberg BA; van Het Schip AD; van Dijk A; Huiskes AW; van Rijk PP
    Nucl Med Commun; 1999 Sep; 20(9):833-6. PubMed ID: 10533189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone scanning and radiography in the evaluation of patients with malignant lymphoma.
    Jánoskuti L; Szilvási I; Papp G; Róna E; Benedek S; Fekete S
    Rofo; 1988 Oct; 149(4):427-8. PubMed ID: 2845515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Osseous scintigraphy in prostatic cancer. Diagnostic and developmental significance].
    Oliveux A; Grob JC; Methlin G; Cinqualbre J; Pellerin JP; Bollack C
    Rev Med Suisse Romande; 1980 Nov; 100(11):905-8. PubMed ID: 7466062
    [No Abstract]   [Full Text] [Related]  

  • 40. FDG avid patchy bone marrow misinterpreted as melanoma metastases to bone in a case of aplastic anemia.
    Okuyama C; Kubota T; Matsushima S; Nishida K; Oda M; Takenaka H; Kishimoto S; Nishimura T
    Clin Nucl Med; 2009 Dec; 34(12):927-30. PubMed ID: 20139838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.